Postprandial administration of the rapid-acting insulin analogue insulin aspart in type 1 diabetic patients

被引：0
|
作者：
Brunner, GA [1 ]
Hirschberger, S [1 ]
Sendlhofer, G [1 ]
Wutte, A [1 ]
Ellmerer, M [1 ]
Schaupp, L [1 ]
Pieber, TR [1 ]
机构：
[1] Graz Univ, Dept Internal Med, A-8010 Graz, Austria
来源：
DIABETOLOGIA | 1999年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
895
引用
收藏
页码：A238 / A238
页数：1
相关论文
共 50 条
  • [1] Effects of the rapid-acting insulin analogue Insulin Aspart on postprandial glycaemic excursions in type 2 diabetes
    Thorsby, P
    Rosenfalck, AM
    Kjems, L
    Hanssen, KF
    Madsbad, S
    Birkeland, KI
    [J]. DIABETOLOGIA, 1999, 42 : A17 - A17
  • [2] Pharmacokinetics of a rapid-acting human insulin analogue, insulin aspart, in children and adolescents with type 1 diabetes
    Mortensen, H
    Olsen, B
    Li'ndholm, A
    [J]. DIABETES, 1999, 48 : A358 - A358
  • [3] The effect of preprandial vs. postprandial administration of rapid-acting insulin analogue on continuous glucose monitoring in type 1 diabetic patients
    Gelber, A.
    Liberty, I. F.
    Perry, Z. H.
    Botach, E.
    Harman-Boehm, I.
    [J]. DIABETOLOGIA, 2008, 51 : S436 - S437
  • [4] Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes
    Bott, U
    Ebrahim, S
    Hirschberger, S
    Skovlund, SE
    [J]. DIABETIC MEDICINE, 2003, 20 (08) : 626 - 634
  • [5] Preclinical safety pharmacology studies on the rapid-acting insulin analogue insulin aspart
    Dall, V
    [J]. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1999, 49 (05): : 463 - 470
  • [6] A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes
    Bramlage, Peter
    Tittel, Sascha R.
    Muether, Silvia
    Reinhart-Steininger, Birgit
    Haberland, Holger
    Khodaverdi, Semik
    Zimny, Stefan
    Ohlenschlaeger, Ute
    Lanzinger, Stefanie
    Haak, Thomas
    [J]. ACTA DIABETOLOGICA, 2022, 59 (11) : 1453 - 1460
  • [7] A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes
    Peter Bramlage
    Sascha R. Tittel
    Silvia Müther
    Birgit Reinhart-Steininger
    Holger Haberland
    Semik Khodaverdi
    Stefan Zimny
    Ute Ohlenschläger
    Stefanie Lanzinger
    Thomas Haak
    [J]. Acta Diabetologica, 2022, 59 : 1453 - 1460
  • [8] Insulin aspart: A new rapid-acting insulin analog
    Setter, SM
    Corbett, CF
    Campbell, RK
    White, JR
    [J]. ANNALS OF PHARMACOTHERAPY, 2000, 34 (12) : 1423 - 1431
  • [9] Distribution and metabolism of the novel rapid-acting insulin analogue insulin Aspart in rats and dogs
    Plum, A
    Hansen, KT
    Andersen, L
    Larsen, UD
    [J]. DIABETES, 1999, 48 : A451 - A451
  • [10] Pharmacokinetics and pharmacodynamics of the rapid-acting analogue insulin Aspart in pediatric/adolescent patients with type I diabetes
    Olsen, B
    Lindholm, A
    Mortensen, H
    Hylleberg, B
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 136A - 136A
12345